EX-10.56 2 dex1056.htm DEVELOPMENT AND LICENSE AGREEMENT Portions of this exhibit marked [*] are requested to be treated confidentially. DEVELOPMENT AND LICENSE AGREEMENT By and Between DEBIOVISION INC. and SALIX PHARMACEUTICALS, INC. September 5,...Development and License Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Development and License Agreement, dated the 5th day of September, 2006 (the “Effective Date”), is by and between SALIX PHARMACEUTICALS, INC., a corporation organized and existing under the laws of California, USA and having its place of business at 1700 Perimeter Park Drive, Morrisville, NC 27560-8404 U.S.A. (“Salix”), and DEBIOVISION INC., a company organized and existing under the laws of Quebec and having its place of business at 666 Sherbrooke Street West, Suite 1400, Montreal, Quebec H3A 1E7, Canada (“Debiovision”).
Portions of this exhibit marked [*] are requested to be treated confidentially. DEVELOPMENT AND LICENSE AGREEMENT By and Between DEBIOVISION INC. and SALIX PHARMACEUTICALS, INC. September 5, 2006Development and License Agreement • November 9th, 2006 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2006 Company Industry JurisdictionThis Development and License Agreement, dated the 5th day of September, 2006 (the “Effective Date”), is by and between SALIX PHARMACEUTICALS, INC., a corporation organized and existing under the laws of California, USA and having its place of business at 1700 Perimeter Park Drive, Morrisville, NC 27560-8404 U.S.A. (“Salix”), and DEBIOVISION INC., a company organized and existing under the laws of Quebec and having its place of business at 666 Sherbrooke Street West, Suite 1400, Montreal, Quebec H3A 1E7, Canada (“Debiovision”).